Medical Marijuana for Cancer - Part 2

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

Today, we will continue discussing the medical marijuana research surrounding cancer in more detail. 

Cannabis provide relief from the nausea associated with chemotherapy, and studies have found CBD not only effectively treats the more difficult symptoms to control of nausea, but also prevents anticipatory nausea in chemotherapy patients. In another study, THC effectively reduced conditioned rejection and chemotherapy-induced nausea. Cannabis also lowers neuropathic pain, and in one study, cancer patients with treatment resistant intractable pain experienced significantly reduced pain levels after two weeks of taking cannabis that contained both THC and CBD. A recent research review described cannabis as having anti-tumor properties and offering pain, nausea, and vomiting relief for patients diagnosed with cancer. 

Many patients undergoing cancer treatments experience weight loss and appetite loss. THC may be able to help, as it has successfully stimulated appetite in patients suffering from cancer-related cachexia. Patients who consume THC report they have larger appetites and food tastes better. A group of 131 cancer patients responded in a survey study that after six to eight weeks of cannabis treatment, they witnessed improvements in all cancer-related symptoms like nausea, vomiting, mood disorders, fatigue, weight loss, anorexia, constipation, sexual function, sleep disorders, itching, and pain. Patients who used THC also slept better and felt more relaxed. Surprisingly, even the government-run National Cancer Institute currently recognizes cannabis as an effective treatment that can provide therapeutic relief for various cancer-related symptoms, including pain, nausea and vomiting, anxiety, and appetite loss. 

This concludes our mini series on cancer and the potential for medical marijuana to be introduced as a powerful therapy. This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.